sargramostim plasmid DNA pancreatic tumor cell vaccine
Term · Oncology and biomedicine · MLC-T-ONC-016646
A whole cell vaccine comprised of irradiated allogenic pancreatic tumor cells transfected with a plasmid DNA encoding human sargramostim (GM-CSF). Vaccination results in expression of GM-CSF, which induces proliferation and differentiation hematopoietic lineage cells as well as stimulating macrophage and dendritic cell functions in antigen presentation and antitumor cell-mediated immunity. Furthermore, administration of this pancreatic tumor cell vaccine may elicit a cytotoxic T lymphocyte (CTL) response against similar host tumor cells, resulting in decreased tumor growth.
| Identifier | MLC-T-ONC-016646 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | GM-CSF plasmid DNA pancreatic tumor cell vaccine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016646",
"term": "sargramostim plasmid DNA pancreatic tumor cell vaccine",
"field": "Oncology and biomedicine",
"definition": "A whole cell vaccine comprised of irradiated allogenic pancreatic tumor cells transfected with a plasmid DNA encoding human sargramostim (GM-CSF). Vaccination results in expression of GM-CSF, which induces proliferation and differentiation hematopoietic lineage cells as well as stimulating macrophage and dendritic cell functions in antigen presentation and antitumor cell-mediated immunity. Furthermore, administration of this pancreatic tumor cell vaccine may elicit a cytotoxic T lymphocyte (CTL) response against similar host tumor cells, resulting in decreased tumor growth.",
"synonyms": [
"GM-CSF plasmid DNA pancreatic tumor cell vaccine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/sargramostim-plasmid-dna-pancreatic-tumor-cell-vaccine/"
}
Record 14,694 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.